These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34021680)

  • 1. Incidence of hyperkalemic RTA in pediatric post-renal transplant patients and the role of fludrocortisone.
    Alabdulqader MA; Azzam A; Alshami AA
    Pediatr Transplant; 2021 Sep; 25(6):e14029. PubMed ID: 34021680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludrocortisone-a treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience.
    Ali SR; Shaheen I; Young D; Ramage I; Maxwell H; Hughes DA; Athavale D; Shaikh MG
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29345400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report.
    Rangel EB; Gomes SA; Machado PG; dos Santos BF; Pestana JO; Pacheco-Silva A; Heilberg IP
    Transplant Proc; 2006 Nov; 38(9):3112-5. PubMed ID: 17112912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludrocortisone Among Adult Renal Transplant Recipients With Persistent Hyperkalemia: Single-Center Experience.
    Gheith OA; Dahab M; Nagib AM; Adel M; Elserwy N; Sobhy I; AbdelMonem M; Abo Atya H; Al-Otaibi T
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):69-73. PubMed ID: 35384810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludrocortisone as a new tool for managing tubulopathy after pediatric renal transplantation: a series of cases.
    Bacchetta J; Basmaison O; Leclerc AL; Bertholet-Thomas A; Cochat P; Ranchin B
    Pediatr Nephrol; 2014 Oct; 29(10):2061-4. PubMed ID: 24908322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature.
    Unsal Y; Baltu D; Gulhan B; Okur FV; Ozaltın F; Düzova A; Topaloğlu R; Ozon ZA; Gonç EN
    Pediatr Transplant; 2024 Jun; 28(4):e14778. PubMed ID: 38767038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludrocortisone Is an Effective Treatment for Hyperkalaemic Metabolic Acidosis in Kidney Transplant Recipients on Tacrolimus: A Case Series.
    Gama RM; Makanjuola D; Wahba M; Quan V; Phanish M
    Nephron; 2022; 146(2):190-196. PubMed ID: 34784594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients.
    Dick TB; Raines AA; Stinson JB; Collingridge DS; Harmston GE
    Transplant Proc; 2011 Sep; 43(7):2664-8. PubMed ID: 21911143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
    Üsküdar Cansu D; Cansu GB; Güvenir S; Korkmaz C
    Rheumatol Int; 2020 Nov; 40(11):1895-1901. PubMed ID: 32166438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludrocortisone therapy for persistent hyperkalaemia.
    Dobbin SJH; Petrie JR; Lean MEJ; McKay GA
    Diabet Med; 2017 Jul; 34(7):1005-1008. PubMed ID: 28375568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series.
    Tahir A; McLaughlin K; Kline G
    BMC Endocr Disord; 2016 Jul; 16(1):43. PubMed ID: 27460219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.
    Singhal PC; Desroches L; Mattana J; Abramovici M; Wagner JD; Maesaka JK
    Am J Nephrol; 1993; 13(2):138-41. PubMed ID: 8342580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Fludrocortisone for Hyperkalemia in Chronic Kidney Disease Not Yet on Dialysis.
    Lee EK; Yang WS
    Electrolyte Blood Press; 2024 Jun; 22(1):8-15. PubMed ID: 38957547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
    Kim DM; Chung JH; Yoon SH; Kim HL
    Nephrol Dial Transplant; 2007 Nov; 22(11):3273-6. PubMed ID: 17616536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients.
    Lin W; Mou L; Tu H; Zhu L; Wang J; Chen J; Hu Y
    J Clin Pharm Ther; 2017 Feb; 42(1):122-124. PubMed ID: 27966241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine nephrotoxicity and early posttransplant hyperkalemia in living-donor renal recipients: report of 4 cases.
    Pavleska-Kuzmanovska S; Popov Z; Ivanovski O; Ristovska V; Masin-Spasovska J; Rambabova-Busljetic I; Ivanovski N
    Exp Clin Transplant; 2014 Oct; 12(5):479-83. PubMed ID: 24417207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables Associated With Hyperkalemic Renal Tubular Acidosis in Solid Organ Transplant Recipients.
    Mohib O; Vanderhulst J; Catalano C; Roussoulières A; Knoop C; Lemoine A; Baudoux T
    Cureus; 2024 Mar; 16(3):e55379. PubMed ID: 38434606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.
    Batlle D; Arruda J
    Adv Chronic Kidney Dis; 2018 Jul; 25(4):321-333. PubMed ID: 30139459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine.
    Kamel KS; Ethier JH; Quaggin S; Levin A; Albert S; Carlisle EJ; Halperin ML
    J Am Soc Nephrol; 1992 Feb; 2(8):1279-84. PubMed ID: 1627752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.